A case report of disappearing pigmented skin lesions associated with pembrolizumab treatment for metastatic melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A case report of disappearing pigmented skin lesions associated with pembrolizumab treatment for metastatic melanoma

Published:2017-09-21 Issue:1 Volume:178 Page:265-269
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Wolner Z.J.¹^ORCID,Marghoob A.A.¹,Pulitzer M.P.²,Postow M.A.³⁴,Marchetti M.A.¹⁴

Affiliation:

1. Department of Medicine Dermatology Service Memorial Sloan Kettering Cancer Center New York NY U.S.A.

2. Department of Pathology Dermatopathology Service Memorial Sloan Kettering Cancer Center New York NY U.S.A.

3. Department of Medicine, Melanoma and Immunotherapeutics Service Memorial Sloan Kettering Cancer Center New York NY U.S.A.

4. Weill Cornell Medical College New York NY U.S.A.

Funder

National Institutes of Health

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.15354

Reference15 articles.

1. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma

2. Toxicities of the anti‐PD‐1 and anti‐PD‐L1 immune checkpoint antibodies;Naidoo J;Ann Oncol,2015

3. Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies

4. Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor

5. Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disappearance of chrysalis structures: a potential sign to differentiate tumoral melanosis from cutaneous melanoma metastases;Italian Journal of Dermatology and Venereology;2024-05

2. Immune checkpoint inhibitor-induced cutaneous toxicities: a review of histopathologic and clinical features;Human Pathology;2023-10

3. Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies;Cancers;2023-06-09

4. Cutaneous Adverse Reactions of Immunotherapy in Patients with Advanced Melanoma;Cancers;2023-03-31

5. Widespread vitiligo and poliosis following ipilimumab–nivolumab combination therapy;Journal of Oncology Pharmacy Practice;2023-02-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3